Glaucoma Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Glaucoma Surgery Devices Pipeline Market Report Overview
Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways to provide effective intra-ocular pressure. Glaucoma drainage devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule forms about 4-6 weeks after surgery and regulates flow.
The glaucoma surgery devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.
| Key Segments | · Glaucoma Drainage Devices
· Minimally Invasive Glaucoma Surgery (MIGS) Devices |
| Key Territories | · The United States
· Europe · China · Israel · Canada |
| Key Regulatory Paths | · PMA
· 510(k) · CE · NMPA · TGA |
| Leading Companies | · Alievio Inc.
· Allergan Ltd · Assenti, LLC · Avisi Technologies LLC · Chongqing Migos Medical Technology Co. Ltd. |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Buy the Full Report for More Insights into the Glaucoma Surgery Devices Pipeline Market
Glaucoma Surgery Devices Pipeline Market Segments
The key segments in the glaucoma surgery devices pipeline market are glaucoma drainage devices and minimally invasive glaucoma surgery (MIGS) devices. Glaucoma drainage devices had the highest number of pipeline products in the glaucoma surgery devices pipeline market as of October 2024. They are small plastic devices that are surgically attached to the eye’s surface to improve or shunt the flow of aqueous drainage.
Glaucoma Surgery Devices Pipeline Market Analysis by Segments, 2024 (%)
Buy the Full Report for More Segment Insights into the Glaucoma Surgery Devices Pipeline Market
Glaucoma Surgery Devices Pipeline Market Segmentation by Territories
The United States (US), Europe, China, Israel, and Canada among others are a few of the key territories of the glaucoma surgery devices pipeline market. As of October 2024, the US accounted for the highest number of pipeline products.
Glaucoma Surgery Devices Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the Glaucoma Surgery Devices Pipeline Market
Glaucoma Surgery Devices Pipeline Market Segmentation by Regulatory Paths
A few of the key regulatory paths in the glaucoma surgery devices pipeline products market are PMA, 510(k), CE, NMPA, and TGA. As of October 2024, PMA was the most followed pathway for pipeline products in the glaucoma surgery devices market.
Glaucoma Surgery Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the Glaucoma Surgery Devices Pipeline Market
Glaucoma Surgery Devices Pipeline Market – Competitive Landscape
A few of the key companies associated with the glaucoma surgery devices pipeline market are Alievio Inc., Allergan Ltd, Assenti, LLC, Avisi Technologies LLC, and Chongqing Migos Medical Technology Co. Ltd., among others.
Alievio Inc: Alievio Inc., headquartered in the US, is an innovative glaucoma medical device company that is developing the first personalized glaucoma treatment to stop vision loss.
Allergan Ltd: Allergan Ltd (Allergan), a subsidiary of AbbVie Inc., is a specialty pharmaceutical company that develops and markets branded pharmaceuticals, biosimilar, and over-the-counter (OTC) pharmaceutical products. The company offers products in the areas of eye care, medical esthetics, dermatology, central nervous system, and other categories. It sells its products to retailers, drug wholesalers, and distributors, including national retail drug and food store chains, mail-order retailers, hospitals, clinics, and other institutions.
Glaucoma Surgery Devices Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the Glaucoma Surgery Devices Pipeline Market
Download a Free Report Sample
Segments Covered in the Report
Glaucoma Surgery Devices Pipeline Market Segments Outlook (2024)
- Glaucoma Drainage Devices
- Minimally Invasive Glaucoma Surgery (MIGS) Devices
Glaucoma Surgery Devices Pipeline Market Territories Outlook (2024)
- The United States
- Europe
- China
- Israel
- Canada
Glaucoma Surgery Devices Pipeline Market Regulatory Paths Outlook (2024)
- PMA
- 510(k)
- CE
- NMPA
- TGA
Scope
This report provides:
- Extensive coverage of the glaucoma surgery devices under development.
- Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
- Reviews of the major players involved in the development of glaucoma surgery devices and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of glaucoma surgery devices under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- Analyze the product’s current stage of development, territory, and estimated launch date.
Allergan Ltd
Assenti, LLC
Avisi Technologies LLC
Chongqing Migos Medical Technology Co Ltd
Ciliatech Therapeutics AG
Corneat Vision Ltd
Eye Sonix
Galaxy Ophthalmics Inc (Inactive)
Geuder AG
Glaucot Teknoloji AS
Glaukos Corp
Health Guard Biomed (Suzhou) Biomedical Technology Co Ltd
HiSilicon (Suzhou) Biomedical Technology Co Ltd
Iantrek Inc
InnFocus Inc
iScience Interventional Inc
iSTAR Medical SA
iVeena Delivery Systems Inc
Johns Hopkins University
Kytogenics Pharmaceuticals Inc
Liqid Medical (Pty) Ltd
Medtronic Plc
Meir Medical Center
Merz Anteis SA
MicroOptx Inc
Mingche Biotechnology (Suzhou) Co Ltd
Myra Vision Inc
Ocumatrx
OcuTherix Inc
OPKO Health Inc
OptoLight Vision Technology
Purdue University
Queen's University
Rheon Medical SA
Sight Sciences Inc
Stanford University
Suzhou Langmu Medical Technology Co Ltd
Tel Aviv University
The Chaim Sheba Medical Center
The University of Texas at Austin Division of Housing and Food Service
University of Colorado
University of Colorado Anschutz Medical Campus
University of Florida
University of Michigan
University of Oslo
Vivid White Pty Ltd
Westhouse Medical Services Plc (Inactive)
Table of Contents
Table
Figures
Frequently asked questions
-
Which territory had the highest number of products in the glaucoma surgery devices pipeline market as of October 2024?
As of October 2024, the US accounted for the highest number of pipeline products in the glaucoma surgery devices market.
-
Which was the most followed regulatory pathway in the glaucoma surgery devices pipeline market as of October 2024?
As of October 2024, PMA was the most followed pathway for pipeline products in the glaucoma surgery devices market.
-
Which are the major companies operating in the glaucoma surgery devices pipeline market?
A few of the key companies associated with the glaucoma surgery devices pipeline market are Alievio Inc., Allergan Ltd, Assenti, LLC, Avisi Technologies LLC, and Chongqing Migos Medical Technology Co. Ltd., among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745


